首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one,an orally active multi-target agent for the treatment of diabetic nephropathy
Authors:Jun Chen  Zhangzhe Peng  Miaomiao Lu  Xuan Xiong  Zhuo Chen  Qianbin Li  Zeneng Cheng  Dejian Jiang  Lijian Tao  Gaoyun Hu
Institution:1. Department of Medicinal Chemistry, Xiangya School of Pharmacy, Central South University, Changsha 410013, China;2. Department of Nephrology, Xiangya Hospital, Central South University, Changsha 410008, China;3. Drug Safety Evaluation Research Center of Hunan Province, Changsha 410331, China
Abstract:Oxidative stress, inflammation and fibrosis can cause irreversible damage on cell structure and function of kidney and are key pathological factors in Diabetic Nephropathy (DN). Therefore, multi-target agents are urgently need for the clinical treatment of DN. Using Pirfenidone as a lead compound and based on the previous research, two novel series (5-trifluoromethyl)-2(1H)-pyridone analogs were designed and synthesized. SAR of (5-trifluoromethyl)-2(1H)-pyridone derivatives containing nitrogen heterocyclic ring have been established for in vitro potency. In addition, compound 8, a novel agent that act on multiple targets of anti-DN with IC50 of 90 μM in NIH3T3 cell lines, t1/2 of 4.89 ± 1.33 h in male rats and LD50 > 2000 mg/kg in mice, has been advanced to preclinical studies as an oral treatment for DN.
Keywords:ACR  albumin-to-creatinine ratio  area under the curve  BuOH  BUN  blood urea nitrogen  peak concentration  CCr  creatinine clearance rate  CCR2  CCchemkin receptor 2  Deuterotrichloromethane  DBM  diabetes model  DMF  N  N-dimethylformamide  DMSO  dimethyl sulfoxide  DN  diabetic nephropathy  ECM  extracellular matrix  ELISA  enzyme-linked immunosorbent assay  ERSD  end stage renal disease  GC-MS  Gas Chromatograph-Mass Spectrometer-computer  GLP  Good laboratory practice of drug  GSI  glomerular sclerosis index  HMBC  heteronuclear multiple bond correlation  HPLC  high performance liquid chromatography  IR  infrared radiation  LC-MS  liquid chromatography-mass spectrum  LPS  lipopolysaccharide  MTT  methylthiazolyl diphenyl tetrazolium bromide  NIH3T3  mouse embryonic fibroblast cell line  NOX  nicotinamide adenine dinucleotide phosphate oxidase  PD  pharmacodynamics  PDGF  platelet-derived growth factor  PFD  pirfenidone  PK  pharmacokinetics  ROS  reactive oxygen species  SAR  structure activity relationships  SCr  serum creatinine  TGF-β  transforming growth factor-β  TNF-α  tumor necrosis factors-α  UUO  unilateral ureteral occlusion  Anti-fibrosis  Anti-inflammatory  Anti-Diabetic Nephropathy  Multi-target  Pyridone derivatives
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号